Skip to main content
Clinical Trials/NCT03029507
NCT03029507
Unknown
N/A

An Acceptance and Commitment Therapy (ACT)-Enhanced Weight Management and Fitness Program for Navy Personnel

Veterans Medical Research Foundation2 sites in 1 country178 target enrollmentDecember 8, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Obesity
Sponsor
Veterans Medical Research Foundation
Enrollment
178
Locations
2
Primary Endpoint
Change in weight from baseline
Last Updated
4 years ago

Overview

Brief Summary

The proposed study is a cohort-randomized controlled trial of Acceptance and Commitment Therapy-enhanced ShipShape (ACT+SS) compared to the standard ShipShape-only program, for overweight or obese Navy personnel. As a result of COVID-19, this study is now being conducted virtually.

Detailed Description

The proposed study is a cohort-randomized controlled trial of ACT-enhanced SS (ACT+SS) compared to the SS-only program. Cohorts of Navy personnel who are failing or at risk of failing the body composition assessment (BCA) or who are overweight/obese will be randomized to receive 8 weekly ACT+SS intervention groups or 8 weekly SS-only intervention groups. The scientific aims are to: 1) determine the effectiveness of ACT+SS compared to the SS-only program; 2) examine psychological flexibility as a mechanism underlying intervention response; and 3) explore potential moderators of intervention response. The primary outcome is weight loss. Secondary outcomes include BMI, body fat %, indices of physical activity, problem eating, functioning and quality of life, emotional functioning and indices of psychological flexibility, measured at baseline, mid- and post-intervention, and 3- and 6-month follow-up and self- reported BCA status at 6-month follow-up. The investigators have purposefully designed a cohort-randomized trial with interventions that are pragmatically implemented in a real-life military setting, and outcomes that are immediately relevant to service members and leadership. The cohort randomization is essential to the feasibility and acceptability of the research in this setting. The military-relevant and generalizable findings are more likely to have impact within the military. SS provides an ideal comparison arm that is the current standard of practice in the Navy. Integrating ACT with SS in this setting overcomes many of the logistical, practical, chain-of-command, and other challenges that have typically impeded research in the military. The investigators have thoughtfully selected primary and secondary outcomes that are theoretically linked, and additional assessments that are empirically-based and will allow better understanding of mediators and moderators of intervention response in Navy personnel. Due to Covid-19 we have adapted the interventions to be administered virtually.

Registry
clinicaltrials.gov
Start Date
December 8, 2017
End Date
July 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Veterans Medical Research Foundation
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Navy Personnel who are overweight/obese or have failed or are at risk of failing the BCA
  • 18-69 years of age
  • Willingness to participate in the study

Exclusion Criteria

  • Any physical limitations (injuries, pregnancy, etc.) that preclude engagement in the physical fitness activities

Outcomes

Primary Outcomes

Change in weight from baseline

Time Frame: Outcome measures will be completed at study baseline (week 1), mid treatment ( week 4), post-treatment (week 8), and 3 and 6 month follow-up post-treatment.

Secondary Outcomes

  • Change in weight related Acceptance and Action Questionnaire for Weight-Related Difficulties-Revised (AAQW-R)(Outcome measures will be completed at study baseline (week 1), mid treatment ( week 4), post-treatment (week 8), and 3 and 6 month follow-up post-treatment.)
  • Change in Three-Factor Eating Questionnaire (TFEQ-R18) score(Outcome measures will be completed at study baseline (week 1), mid treatment ( week 4), post-treatment (week 8), and 3 and 6 month follow-up post-treatment.)
  • Change in Satisfaction with Life Scale (SWLS)(Outcome measures will be completed at study baseline (week 1), mid treatment ( week 4), post-treatment (week 8), and 3 and 6 month follow-up post-treatment.)

Study Sites (2)

Loading locations...

Similar Trials